Literature DB >> 10210765

[Breast cancer in Tunisia: clinical and epidemiological study].

M Maalej1, H Frikha, S Ben Salem, J Daoud, N Bouaouina, M Ben Abdallah, K Ben Romdhane.   

Abstract

This study has been realized to determine epidemiological profile and clinicopathologic aspect of breast cancer in Tunisia. We have counted and analyzed all cancers of the breast diagnosed in Tunisia with proof pathologic or to defect cytologic of malignancy, between first January 1994 and 31 December 1994. In the course of this year, 689 new cases of mammary cancers have been diagnosed at the women. The average patient age was 50.0 years, the incidence standardized on the age of the cancer of the breast in Tunisia was 16.7/100,000 women. The average size of the tumor was 49.5 mm (35.8 mm at patients processed in private clinics and 50.7 mm at patients processed in the public hospitals). According to TNM classification of 1988, 7.2% of tumors were classified T1, 48.9% T2, 18.5% T3, and 23.4% T4 (6.2% T4d and 16.1% T4b). 22.1% of tumors were M1. 3.3% were in situ carcinoma. For the infiltrants cancers, the grade II SBR has been the most frequent (53.6%). On the therapeutic plan, the conservative processing has been practiced only at 17.6% of patients. The cancer of the breast in Tunisia rest again relatively little frequent, and its clinic profile resides alarming. The inflammatory cancer notion of the breast (equal T4d) intimately linked to Tunisia overestimates probably the reality. Cancers that were classified "PEV" in many publications would be in reality only for most of locally evolved and neglected cancers.

Entities:  

Mesh:

Year:  1999        PMID: 10210765

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  10 in total

1.  Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt.

Authors:  Brooke Spencer; Mousumi Banerjee; Sherif Omar; Hussein Khaled; Nayera Anwar; Mohamed S Zaghloul; Saad Eissa; Celina G Kleer; Subhojit Dey; Sofia D Merajver; Amr S Soliman
Journal:  Breast J       Date:  2011-08-09       Impact factor: 2.431

2.  Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer.

Authors:  Mansour Al-Moundhri; V Nirmala; K Al-Mawaly; S Ganguly; I Burney; A Rizvi; C Grant
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

3.  Male breast cancer: 22 case reports at the National Hospital of Niamey-Niger (West Africa).

Authors:  Sani Rachid; Harouna Yacouba; Nouhou Hassane
Journal:  Pan Afr Med J       Date:  2009-11-16

4.  Significance of Her-2/neu protein over expression in Indian breast cancer patients.

Authors:  Vikash Kumar; Mallika Tewari; Usha Singh; H S Shukla
Journal:  Indian J Surg       Date:  2008-07-30       Impact factor: 0.656

5.  Breast cancer in low- and middle-income countries: an emerging and challenging epidemic.

Authors:  Arafat Tfayli; Sally Temraz; Rachel Abou Mrad; Ali Shamseddine
Journal:  J Oncol       Date:  2010-12-15       Impact factor: 4.375

6.  Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.

Authors:  Wijden Mahfoudh; Noureddine Bouaouina; Slim Ben Ahmed; Sallouha Gabbouj; Jingxuan Shan; Rebecca Mathew; Nancy Uhrhammer; Yves-Jean Bignon; Wafa Troudi; Amel Ben Ammar Elgaaied; Elham Hassen; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

7.  Organization and Evaluation of Performance Indicators of a Breast Cancer Screening Program in Meknes-Tafilalt Region, Morocco

Authors:  Hafida Charaka; Mohamed Khalis; Samira Elfakir; Youssef Chami Khazraji; Ahmed Zidouh; Loubna Abousselham; Karima El Rhazi; Badiaa Lyoussi; Chakib Nejjari
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

Review 8.  An update on the management of breast cancer in Africa.

Authors:  V Vanderpuye; S Grover; N Hammad; H Simonds; F Olopade; D C Stefan
Journal:  Infect Agent Cancer       Date:  2017-02-14       Impact factor: 2.965

9.  Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.

Authors:  Jason A Zell; Walter Y Tsang; Thomas H Taylor; Rita S Mehta; Hoda Anton-Culver
Journal:  Breast Cancer Res       Date:  2009-02-19       Impact factor: 6.466

10.  Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.

Authors:  Lobna Ayadi; Abdelmajid Khabir; Habib Amouri; Sondes Karray; Abdallah Dammak; Mohamed Guermazi; Tahya Boudawara
Journal:  World J Surg Oncol       Date:  2008-10-22       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.